• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Successful arterial substitution with modified human umbilical vein.

作者信息

Dardik H, Dardik I I

出版信息

Ann Surg. 1976 Mar;183(3):252-8. doi: 10.1097/00000658-197603000-00006.

DOI:10.1097/00000658-197603000-00006
PMID:816263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1344232/
Abstract

Human umbilical veins were prepared as vascular grafts by tanning with dialdehyde starch or gluteraldehyde and by structural re-inforcement with an outer polyester fiber mesh. These grafts were implanted in baboons in the aortoiliac position for periods of 3 days to 9 months. There was no aneurysm formation and there was an excellent maintenance of patency as well as function. Histologic evaluation of the graft materials showed a dense collagen layer within the encircling polyester fiber mesh. A multicellular subintimal layer formed a discrete inner capsule. The inflammatory response with the umbilical component was insignificant. There was no evidence of rejection. This study suggests that the modified umbilical vein can serve as a satisfactory blood conduit. Experience with three short-term clinical implants supports the applicability and potential for this new vascular graft.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ab/1344232/7ef12f6395b7/annsurg00277-0057-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ab/1344232/97531dcb9ca7/annsurg00277-0053-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ab/1344232/173fc33f7d55/annsurg00277-0053-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ab/1344232/70178d9d6e70/annsurg00277-0054-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ab/1344232/605f00b46486/annsurg00277-0055-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ab/1344232/36b2b1b11512/annsurg00277-0055-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ab/1344232/a2d81467f6de/annsurg00277-0056-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ab/1344232/cb6b791c4fb3/annsurg00277-0056-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ab/1344232/43a0160be199/annsurg00277-0057-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ab/1344232/7ef12f6395b7/annsurg00277-0057-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ab/1344232/97531dcb9ca7/annsurg00277-0053-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ab/1344232/173fc33f7d55/annsurg00277-0053-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ab/1344232/70178d9d6e70/annsurg00277-0054-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ab/1344232/605f00b46486/annsurg00277-0055-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ab/1344232/36b2b1b11512/annsurg00277-0055-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ab/1344232/a2d81467f6de/annsurg00277-0056-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ab/1344232/cb6b791c4fb3/annsurg00277-0056-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ab/1344232/43a0160be199/annsurg00277-0057-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ab/1344232/7ef12f6395b7/annsurg00277-0057-b.jpg

相似文献

1
Successful arterial substitution with modified human umbilical vein.
Ann Surg. 1976 Mar;183(3):252-8. doi: 10.1097/00000658-197603000-00006.
2
Clinical experience with modified human umbilical cord vein for arterial bypass.
Surgery. 1976 Jun;79(6):618-24.
3
Arteriovenous fistulas constructed with modified human umbilical cord vein graft.
Arch Surg. 1976 Jan;111(1):60-2. doi: 10.1001/archsurg.1976.01360190062010.
4
Modified and unmodified umbilical vein allografts and xenografts as arterial substitutes: morphologic assessment.
Surg Forum. 1975;26:286-7.
5
Umbilical vein grafts.脐静脉移植物
Ann Surg. 1978 Apr;187(4):440-1. doi: 10.1097/00000658-197804000-00021.
6
The fate of human umbilical cord vessels used as interposition arterial grafts in the baboon.
Surg Gynecol Obstet. 1975 Apr;140(4):567-71.
7
Processed human umbilical cord veins for vascular reconstructive surgery.
Trans Am Soc Artif Intern Organs. 1976;22:514-26.
8
Evaluation of modified human umbilical vein as an arterial substitute in femoropopliteal reconstructive surgical procedures.
Surg Gynecol Obstet. 1978 Nov;147(5):721-5.
9
Experimental and clinical use of human umbilical cord vessels as vascular substitutes.
J Cardiovasc Surg (Torino). 1977 Nov-Dec;18(6):555-9.
10
Human umbilical cord vein for vascular replacement: preliminary report and observations.
Surgery. 1977 Feb;81(2):152-60.

引用本文的文献

1
Commentary: Still searching for the Holy Grail 70 years later: I can see some light.评论：70年后仍在寻找圣杯：我看到了一丝曙光。
JTCVS Open. 2021 Mar 24;6:159-160. doi: 10.1016/j.xjon.2021.03.008. eCollection 2021 Jun.
2
The application of tissue-engineered fish swim bladder vascular graft.组织工程化鱼鳔血管移植物的应用。
Commun Biol. 2021 Oct 5;4(1):1153. doi: 10.1038/s42003-021-02696-9.
3
Application of the Tissue-Engineered Plant Scaffold as a Vascular Patch.组织工程化植物支架作为血管补片的应用。

本文引用的文献

1
Late occlusion of femoral and popliteal fabric arterial grafts.
Surg Gynecol Obstet. 1960 Jun;110:714-8.
2
Antigenicity of homografted veins.同种移植静脉的抗原性。
Surgery. 1967 Mar;61(3):471-7.
3
Experiences with modified bovine carotid arteries in arterial surgery.改良牛颈动脉在动脉手术中的应用经验。
Surgery. 1970 Dec;68(6):1064-73.
ACS Omega. 2021 Apr 23;6(17):11595-11601. doi: 10.1021/acsomega.1c00804. eCollection 2021 May 4.
4
Human Perinatal-Derived Biomaterials.人围产期来源生物材料。
Adv Healthc Mater. 2017 Sep;6(18). doi: 10.1002/adhm.201700345. Epub 2017 Aug 7.
5
The consequence of biologic graft processing on blood interface biocompatibility and mechanics.生物移植物处理对血液界面生物相容性和力学性能的影响。
Cardiovasc Eng Technol. 2015 Sep;6(3):303-13. doi: 10.1007/s13239-015-0221-2.
6
Development of decellularized human umbilical arteries as small-diameter vascular grafts.脱细胞人脐动脉作为小口径血管移植物的研发
Tissue Eng Part A. 2009 Sep;15(9):2665-76. doi: 10.1089/ten.tea.2008.0526.
7
Modified human umbilical vein graft arteriovenous fistulae as a source of angioaccess in maintenance hemodialysis.改良人脐静脉移植物动静脉内瘘作为维持性血液透析血管通路的来源
Cardiovasc Dis. 1980 Mar;7(1):51-57.
8
FEMORAL POPLITEAL BYPASS EMPLOYING MODIFIED HUMAN UMBILICAL CORD VEIN: AN ASSESSMENT OF EARLY CLINICAL RESULTS.采用改良人脐静脉的股腘动脉旁路移植术：早期临床结果评估
Cardiovasc Dis. 1976;3(3):314-319.
9
Experimental studies on arterial reconstruction with bovine pericardial tube.
Acta Acad Med Wuhan. 1982;2(2):108-13. doi: 10.1007/BF02908875.
10
Biodegradation and aneurysm formation in umbilical vein grafts. Observations and a realistic strategy.脐静脉移植物中的生物降解与动脉瘤形成。观察结果及切实可行的策略。
Ann Surg. 1984 Jan;199(1):61-8. doi: 10.1097/00000658-198401000-00011.
4
Prolonged survival of glutaraldehyde-treated skin homografts.经戊二醛处理的皮肤同种异体移植物的长期存活
Proc Natl Acad Sci U S A. 1971 Jul;68(7):1590-3. doi: 10.1073/pnas.68.7.1590.
5
Clinical experience with preserved human allografts for vascular reconstruction.
Surgery. 1972 Aug;72(2):260-7.
6
Future directions in the development of arterial prostheses for small and medium caliber arteries.
Surg Clin North Am. 1974 Feb;54(1):213-28. doi: 10.1016/s0039-6109(16)40245-8.
7
Femoropopliteal composite dacron and autogenous vein bypass grafts. A preliminary report.股腘动脉涤纶与自体静脉复合搭桥术。初步报告。
Arch Surg. 1973 Nov;107(5):748-53. doi: 10.1001/archsurg.1973.01350230100019.
8
Silicone mandril method for growing reinforced autogenous femoro-popliteal artery grafts in situ.用于原位生长强化自体股腘动脉移植物的硅胶芯棒法
Ann Surg. 1973 Mar;177(3):293-300. doi: 10.1097/00000658-197303000-00009.
9
Vascular heterograft: human umbilical cord vein as an aortic substitute in baboon. A preliminary report.
J Med Primatol. 1973;2(5):296-301. doi: 10.1159/000460338.
10
Antigenicity of vascular heterografts.
J Surg Res. 1973 Aug;15(2):81-6. doi: 10.1016/0022-4804(73)90146-7.